Saturday 17 October 2026
Export SYK’s income statement to Excel — free account
Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
294.66
1.43
+0.49%
Follow SYK
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
41.40 | 45.87 | 35.52 | 39.49 | 50.55 | 57.39 | 37.69 | 16.52 | 57.84 | 27.08 |
Piotroski F-Score |
5 | 6 | 7 | 6 | 8 | 3 | 5 | 3 | 5 | 7 |
P/S ratio |
5.35 | 6.07 | 5.49 | 5.04 | 5.89 | 6.41 | 5.28 | 4.31 | 4.75 | 3.95 |
Altman Z-Score |
4.81 | 5.30 | 4.76 | 4.18 | 4.54 | 3.90 | 4.31 | 3.85 | 4.56 | 4.26 |
Altman Z″-Score (non-manufacturers) |
3.96 | 4.06 | 3.70 | 3.39 | 3.60 | 3.16 | 4.10 | 3.90 | 4.21 | 4.56 |
P/FCF ratio |
31.36 | 39.34 | 35.86 | 45.70 | 36.82 | 32.98 | 50.92 | 28.77 | 61.45 | 31.35 |
Beneish M-Score |
(2.62) | (2.57) | (2.50) | (2.32) | (2.54) | (2.72) | (2.28) | (2.28) | (2.45) | (2.34) |
P/Operating CF |
62.68 | 71.04 | 73.59 | 92.77 | 100.82 | 74.38 | 106.83 | 56.06 | 86.97 | 67.90 |
Dividend Safety Score |
82 | — | — | — | — | — | — | — | — | — |
P/B ratio |
5.99 | 6.65 | 6.05 | 5.60 | 6.78 | 7.03 | 6.13 | 5.00 | 5.92 | 4.68 |
Price to Tangible BV |
0.00 | 357.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.82 | 6.47 | 5.97 | 5.65 | 6.45 | 7.18 | 5.72 | 4.76 | 5.10 | 4.26 |
EV/EBITDA |
24.02 | 30.87 | 24.90 | 27.13 | 30.86 | 33.93 | 24.40 | 19.88 | 21.60 | 17.72 |
EV/Operating CF |
28.96 | 34.48 | 32.98 | 39.70 | 33.80 | 31.42 | 38.88 | 24.83 | 40.72 | 25.17 |
EV/FCF |
34.11 | 41.95 | 39.03 | 51.16 | 40.28 | 36.91 | 55.24 | 31.80 | 66.06 | 33.83 |
Quick Ratio |
1.04 | 1.11 | 0.86 | 0.87 | 1.33 | 1.14 | 1.66 | 1.25 | 1.43 | 1.70 |
Current Ratio |
1.89 | 1.95 | 1.58 | 1.63 | 2.20 | 1.93 | 2.51 | 2.02 | 2.29 | 2.50 |
Net Debt/EBITDA |
1.93 | 1.92 | 2.02 | 2.90 | 2.65 | 3.61 | 1.91 | 1.89 | 1.51 | 1.30 |
Debt/Assets |
33.15% | 31.64% | 32.56% | 35.38% | 36.03% | 40.75% | 36.76% | 36.21% | 32.54% | 33.83% |
Debt/Equity |
0.71 | 0.66 | 0.70 | 0.79 | 0.84 | 1.07 | 0.87 | 0.84 | 0.72 | 0.72 |
Asset Turnover |
0.55 | 0.55 | 0.53 | 0.52 | 0.50 | 0.45 | 0.52 | 0.55 | 0.58 | 0.62 |
Operating CF/Net income |
1.55 | 1.42 | 1.17 | 1.11 | 1.64 | 2.05 | 1.05 | 0.73 | 1.53 | 1.16 |
Capex/Depreciation |
(0.64) | (0.72) | (0.56) | (0.59) | (0.53) | (0.60) | (0.83) | (0.79) | (0.93) | (0.90) |
Interest Coverage |
8.05 | 9.02 | 10.71 | 30.22 | 38.00 | 21.79 | 17.50 | 21.32 | 38.28 | 75.00 |
| 15.08% | 15.26% | 17.98% | 14.97% | 14.26% | 12.35% | 16.98% | 32.73% | 10.45% | 18.24% | |
| 7.15% | 7.22% | 8.24% | 6.59% | 5.78% | 4.96% | 7.26% | 14.38% | 4.79% | 8.99% | |
ROIC |
8.94% | 7.75% | 8.52% | 6.40% | 6.64% | 5.78% | 8.71% | 8.86% | 9.96% | 10.39% |
Return on Tangible Assets |
29.95% | 28.03% | 40.51% | 33.97% | 24.02% | 21.56% | 22.58% | 49.23% | 15.73% | 26.22% |
Average Days of Receivables |
58.70 | 64.41 | 67.04 | 70.53 | 64.47 | 68.70 | 70.95 | 62.58 | 64.47 | 63.40 |
Research and Development Expense of Revenue |
6.46% | 6.49% | 6.77% | 7.88% | 7.22% | 6.86% | 6.52% | 6.34% | 6.32% | 6.31% |
Selling, General and Administrative Expense of Revenue |
34.44% | 34.01% | 34.69% | 34.61% | 37.57% | 37.36% | 35.98% | 37.49% | 36.58% | 36.53% |
Intangible Assets out of Total Assets |
0.52 | 0.47 | 0.50 | 0.54 | 0.51 | 0.53 | 0.44 | 0.47 | 0.48 | 0.48 |
Share Based Compensation of Revenue |
0.97% | 1.01% | 1.00% | 0.91% | 1.00% | 0.99% | 0.85% | 0.87% | 0.91% | 0.86% |
Graham Net Nets |
(0.08) | (0.05) | (0.08) | (0.11) | (0.10) | (0.13) | (0.08) | (0.10) | (0.07) | (0.07) |
Graham Number |
105.86 | 97.80 | 95.87 | 78.48 | 68.53 | 57.86 | 65.51 | 81.82 | 40.49 | 50.33 |
Earnings Yield |
2.42% | 2.18% | 2.82% | 2.53% | 1.98% | 1.74% | 2.65% | 6.05% | 1.73% | 3.69% |
Free Cash Flow Yield |
3.19% | 2.54% | 2.79% | 2.19% | 2.72% | 3.03% | 1.96% | 3.48% | 1.63% | 3.19% |
Revenue per Share |
65.71 | 59.30 | 54.00 | 48.78 | 45.38 | 38.22 | 39.80 | 36.36 | 33.27 | 30.27 |
Operating CF per Share |
13.20 | 11.13 | 9.78 | 6.94 | 8.66 | 8.73 | 5.86 | 6.98 | 4.17 | 5.12 |
Capex per Share |
(1.99) | (1.98) | (1.51) | (1.55) | (1.39) | (1.30) | (1.74) | (1.53) | (1.60) | (1.31) |
Free Cash Flow per Share |
11.21 | 9.15 | 8.26 | 5.38 | 7.26 | 7.43 | 4.12 | 5.45 | 2.57 | 3.81 |
Cash per Share |
10.73 | 11.79 | 8.04 | 5.10 | 8.01 | 8.05 | 11.83 | 9.89 | 7.47 | 9.05 |
Shareholders Equity per Share |
58.66 | 54.16 | 48.98 | 43.93 | 39.46 | 34.84 | 34.24 | 31.36 | 26.68 | 25.53 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
58.66 | 54.16 | 48.98 | 43.93 | 39.46 | 34.84 | 34.24 | 31.36 | 26.68 | 25.53 |
Free Cash Flow |
4,283.00 | 3,487.00 | 3,136.00 | 2,036.00 | 2,738.00 | 2,790.00 | 1,542.00 | 2,038.00 | 961.00 | 1,425.00 |
Working Capital |
6,961.00 | 7,231.00 | 4,597.00 | 3,972.00 | 5,468.00 | 4,666.00 | 6,658.00 | 4,926.00 | 4,508.00 | 4,713.00 |
Capital Expenditures |
(761.00) | (755.00) | (575.00) | (588.00) | (525.00) | (487.00) | (649.00) | (572.00) | (598.00) | (490.00) |
Net Current Asset Value |
(10,669.00) | (7,490.00) | (8,801.00) | (9,993.00) | (9,737.00) | (11,539.00) | (6,302.00) | (5,766.00) | (4,224.00) | (3,024.00) |
EV/EBIT |
29.88 | 39.65 | 31.48 | 36.67 | 42.68 | 46.32 | 31.40 | 25.54 | 27.64 | 22.16 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 |
Price to Operating Income |
27.48 | 37.19 | 28.92 | 32.75 | 39.02 | 41.39 | 28.94 | 23.11 | 25.71 | 20.54 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.30 | 0.32 | 0.34 | 0.35 | 0.30 | 0.30 | 0.32 | 0.33 | 0.35 |
Cash ROIC |
10.11% | 9.00% | 9.05% | 6.44% | 9.01% | 9.27% | 5.44% | 8.06% | 4.81% | 7.18% |
Accounts Receivable Turnover |
6.26 | 5.83 | 5.59 | 5.60 | 5.98 | 5.13 | 5.70 | 6.00 | 5.98 | 6.24 |
Accounts Payable Turnover |
5.20 | 5.10 | 5.08 | 5.41 | 6.33 | 7.13 | 7.85 | 8.23 | 9.23 | 9.02 |
Inventory Turnover |
1.80 | 1.70 | 1.68 | 1.88 | 1.80 | 1.64 | 1.75 | 1.72 | 1.90 | 2.08 |
Average Days of Payables |
72.55 | 75.15 | 74.42 | 75.06 | 67.11 | 55.85 | 47.49 | 50.57 | 41.69 | 41.74 |
Days of Inventory on Hand |
214.14 | 213.67 | 237.59 | 212.22 | 197.00 | 240.90 | 209.66 | 231.31 | 211.00 | 193.92 |
Average Receivables |
4,013.00 | 3,876.00 | 3,665.00 | 3,293.50 | 2,861.50 | 2,797.00 | 2,612.50 | 2,265.00 | 2,082.50 | 1,814.50 |
Average Payables |
1,739.00 | 1,598.00 | 1,465.00 | 1,271.00 | 969.50 | 742.50 | 660.50 | 566.50 | 462.00 | 423.50 |
Average Inventory |
5,042.00 | 4,808.50 | 4,419.00 | 3,654.50 | 3,404.00 | 3,237.00 | 2,967.50 | 2,710.00 | 2,247.50 | 1,834.50 |
Average Assets |
45,407.50 | 41,441.50 | 38,398.00 | 35,757.50 | 34,480.50 | 32,248.50 | 28,698.00 | 24,713.00 | 21,316.00 | 18,329.00 |
Average Common Equity |
21,527.00 | 19,613.50 | 17,604.50 | 15,746.50 | 13,980.50 | 12,945.50 | 12,268.50 | 10,855.00 | 9,765.00 | 9,030.50 |
Columns are period end dates